Multidisciplinary Care for Pulmonary Embolism
Pulmonary embolism (PE) calls for a coordinated clinical approach. A new paradigm for care for PE was developed at Mass General.
What is PERT and How Can it Help Triage the PE Patient?
Kenneth Rosenfield, MD, of Mass General, discusses PERT, an institutionally-based multidisciplinary team that rapidly assesses and treats PE patients.
Studies Work to Improve Pulmonary Hypertension and HHT Care
Research at Massachusetts General Hospital seeks to expand indications for pulmonary hypertension treatments, cure chronic thromboembolic pulmonary hypertension with novel surgeries and help primary care providers treat hereditary hemorrhagic telangiectasia.
Early Data Suggest Caution with Empiric Escalation of Anticoagulation in COVID-19
A substantial rate of bleeding in patients with COVID-19 suggests caution with routine escalation of anticoagulation beyond standard doses.
FlowTriever System Is Safe, Effective for Treating Intermediate-Risk Pulmonary Embolism
In the first prospective trial of mechanical thrombectomy for acute intermediate-risk pulmonary embolism, the effectiveness and safety profiles of the FlowTriever Retrieval/Aspiration System were comparable to those of catheter-directed thrombolysis.
Despite Advanced Therapies, Mortality from Pulmonary Embolism Remains High
Advanced therapies for pulmonary embolism are independently associated with reduced risk of 90-day mortality, according to a review of a prospective database at Massachusetts General. However, overall mortality rates remain substantial.
Pulmonary Embolism Contributors
Kenneth Rosenfield, MD, MHCDS
Section Head, Vascular Medicine and Intervention, Chairman, STEMI & Acute MI Quality Improvement Committee
Mass General Brigham Study Suggests Optimal Treatment for Limb Threatening Ischemia
Rachel P. Rosovsky, MD
Hematologist, PERT Executive Committee Member
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19